| Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived200 of 436show all (up to 200) |
|---|
| → investigated in trials for | Cyclophosphamidesmall molecule 573 trials (127 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 573 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 401 trials (76 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 401 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cytarabinesmall molecule 304 trials (36 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 304 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rituximabmonoclonal antibody 252 trials (58 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 252 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 245 trials (86 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 245 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 219 trials (26 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 219 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 214 trials (28 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 214 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 211 trials (84 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 211 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 196 trials (11 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 196 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 185 trials (8 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 185 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 182 trials (78 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 182 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 173 trials (45 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 173 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 170 trials (38 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 170 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 165 trials (32 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 165 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 162 trials (21 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 162 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall_molecule 160 trials (41 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 160 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 155 trials (8 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 155 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 151 trials (37 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 151 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 149 trials (66 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 149 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 145 trials (22 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 145 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 130 trials (15 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 130 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 111 trials (16 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 111 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 110 trials (23 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 110 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 106 trials (15 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 106 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 105 trials (27 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 105 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 105 trials (34 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 105 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 100 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 100 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daunorubicinsmall molecule 95 trials (9 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 95 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 93 trials (25 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 93 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 92 trials (12 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 92 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 90 trials (53 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 90 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 86 trials (13 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 86 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall molecule 85 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 85 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 83 trials (36 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 83 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Venetoclaxsmall_molecule 80 trials (47 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 80 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mercaptopurinesmall molecule 78 trials (18 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 78 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 74 trials (10 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 74 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idarubicinsmall molecule 74 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 74 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 72 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 72 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 71 trials (44 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 71 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 67 trials (12 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 67 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 65 trials (18 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 65 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitoxantronesmall molecule 63 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 63 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 62 trials (31 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 62 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibrutinibsmall molecule 61 trials (18 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 61 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 60 trials (11 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 60 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Regorafenibsmall molecule 59 trials (14 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 59 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 56 trials (10 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 56 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 55 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 55 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 53 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 53 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alemtuzumabmonoclonal antibody 52 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 52 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thiotepasmall molecule 51 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 51 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 50 trials (25 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 50 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Blinatumomabmonoclonal antibody 49 trials (33 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 49 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 49 trials (25 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 49 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Clofarabinesmall molecule 48 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 48 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 47 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 47 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinibsmall molecule 47 trials (11 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 47 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Asparaginaseother 46 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 46 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegaspargaseother 46 trials (12 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 46 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 46 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 46 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall_molecule 46 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 46 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 44 trials (12 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 44 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thioguaninesmall molecule 44 trials (8 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 44 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 43 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 43 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 41 trials (16 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 41 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ifosfamidesmall molecule 41 trials (9 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 41 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 38 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 38 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 38 trials (27 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 38 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 37 trials (11 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 37 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Arsenic Trioxidesmall molecule 35 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bendamustinesmall molecule 35 trials (11 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 34 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 31 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 31 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemtuzumab Ozogamicinadc 31 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 31 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 31 trials (8 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 31 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 30 trials (15 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 30 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 29 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nilotinibsmall molecule 27 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 26 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carmustinesmall molecule 25 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 25 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 25 trials (8 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axitinibsmall molecule 24 trials (8 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisolonesmall molecule 24 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvocidibsmall molecule 23 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ofatumumabmonoclonal antibody 23 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanubrutinibsmall_molecule 23 trials (17 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 22 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panitumumabmonoclonal antibody 22 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pazopanibsmall molecule 22 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cladribinesmall molecule 21 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal antibody 21 trials (13 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 20 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tretinoinsmall molecule 20 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 20 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gefitinibsmall molecule 19 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Inotuzumab Ozogamicinadc 19 trials (14 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epcoritamabmonoclonal antibody 18 trials (15 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Niraparibsmall molecule 18 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pentostatinsmall molecule 18 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 18 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tanespimycinsmall molecule 17 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tipifarnibsmall molecule 17 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Celecoxibsmall molecule 16 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 16 trials (12 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epirubicinsmall molecule 16 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mosunetuzumabmonoclonal antibody 16 trials (13 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afliberceptother 15 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 15 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 15 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFOX Regimen 15 trials (6 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panobinostatsmall molecule 15 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Perifosinesmall molecule 15 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Polatuzumab Vedotinadc 15 trials (11 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ramucirumabmonoclonal antibody 15 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 15 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selumetinibsmall molecule 15 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Volasertibsmall molecule 15 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 14 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Acalabrutinibsmall molecule 14 trials (9 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxyureasmall molecule 14 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lapatinibsmall molecule 13 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nelarabinesmall molecule 13 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nintedanibsmall molecule 13 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ripretinibsmall molecule 13 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tisagenlecleucelcell therapy 13 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 12 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carfilzomibother 12 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cixutumumabmonoclonal antibody 12 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFIRI Regimen 12 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitomycinsmall molecule 12 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 12 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pirtobrutinibsmall molecule 12 trials (8 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adebrelimabmonoclonal antibody 11 trials (6 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 11 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 11 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Quizartinibsmall molecule 11 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 11 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall_molecule 11 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aspirinsmall molecule 10 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Eribulinsmall molecule 10 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fruquintinibsmall molecule 10 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fulvestrantsmall molecule 10 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Glofitamabmonoclonal antibody 10 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxychloroquinesmall molecule 10 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegargiminaseother 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Plerixaforsmall molecule 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ponatinibsmall molecule 10 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ribociclibsmall molecule 10 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tagraxofuspother 10 trials (6 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tegafursmall molecule 10 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vemurafenibsmall_molecule 10 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 9 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Letrozolesmall molecule 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pomalidomidesmall molecule 9 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sonidegibsmall molecule 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 9 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vandetanibsmall_molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall_molecule 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axicabtagene Ciloleucelgene therapy 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bosutinibsmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Calaspargase Pegolother 8 trials (8 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daratumumabmonoclonal antibody 8 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dovitinibsmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enfortumab Vedotinadc 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumab/Nivolumab Regimen 8 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Loncastuximab Tesirineadc 8 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Osimertinibsmall molecule 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Serplulimabmonoclonal antibody 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tafasitamabmonoclonal antibody 8 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Valproic Acidsmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vindesinesmall_molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adjuvant Chemotherapy 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avapritinibsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Buparlisibsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crizotinibsmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenibsmall molecule 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Denosumabmonoclonal antibody 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erdafitinibsmall molecule 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFOX-4 Regimen 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idelalisibsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immune Checkpoint Inhibitor 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Letetresgene Autoleucelgene therapy 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lisocabtagene Maraleucelgene therapy 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lomustinesmall molecule 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Midostaurinsmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitotanesmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Peginterferon Alfa-2bother 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Revumenibsmall molecule 7 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talazoparibsmall molecule 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alectinibsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Amsacrinesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | CAPOX Regimen 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chlorambucilsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm | 6 | Observed | clinicaltrials | graph → |